NCT05118581

Safety and Efficacy of Ultrasound Guided Vascular Access

Status unknown NA Last updated 16 November 2021

What this trial tests

NA trial testing ultrasound guided vascular access in Vascular Access in 100 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
1 December 2022

30 December 2022

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	100
Start date	1 December 2021
Primary completion	1 December 2022
Estimated completion	30 December 2022

Drugs / interventions tested

• ultrasound guided vascular access

Conditions studied

• Vascular Access — all drugs for Vascular Access →
• Ultrasound Guided Vascular Access — all drugs for Ultrasound Guided Vascular Access →

Sponsor

Sohag University

Who can join

18 and older, any sex, with Vascular Access or Ultrasound Guided Vascular Access. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vascular access involves central and peripheral vein accesses and arterial accesses. Central venous catheterization is widely used in clinical practice for diverse purposes, including hemodialysis for end stage renal failure, invasive hemodynamic monitoring, radiological studies, infusion of drugs that cannot be administered via peripheral vessels, administration of parenteral nutrition, vascular access in patients whose peripheral veins are difficult to be catheterized and for miscellaneous purposes that require access to large caliber vessels.

Arterial cannulation is used for invasive arterial pressure monitoring and to ensure access for diagnostic and therapeutic interventions.

In the United States and United Kingdom, guidelines have recommended the use of ultrasound guidance to reduce complications and improve success in central venous catheterization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.